Search Articles :
Re-size text: Decrease Text Size Increase Text Size

Cancer Specialist Joins Stephenson Cancer Center

Thursday, March 3, 2016 - Campus News -
GhaniSofia.jpg
 

Sofia Ghani, M.D., a hematologist-oncologist, has established her medical practice with the Stephenson Cancer Center. She has also been named an assistant professor of hematology oncology for the University of Oklahoma College of Medicine. 

Ghani has a special interest in diagnosing and treating patients with genitourinary malignancies including kidney, bladder, prostate and testicular cancer. She is board certified in medical oncology, hematology and internal medicine.

Ghani completed a fellowship in hematology/medical oncology at Roswell Park Cancer Institute, Buffalo, New York, where she also served as the Chief Administrative Fellow. She completed an internal medicine residency at Weill Cornell Medical College of Cornell University, Brooklyn, New York. She earned her medical degree in Pakistan.

She is a member of the American Society of Clinical Oncology and American Society of Hematology.

Ghani sees patients at the Stephenson Cancer Center, 800 N.E. 10th Street. For an appointment, call (405) 271-8299. 

Oklahoma’s only comprehensive academic cancer center, the Stephenson Cancer Center at the University of Oklahoma is a nationally noted leader in research and patient care. The Stephenson Cancer Center annually ranks among the top three cancer centers in the nation for patients participating in National Cancer Institute-sponsored treatment trials, and it is one of 30 designated lead centers nationally in the Institute’s National Clinical Trials Network. In collaboration with the Oklahoma Tobacco Settlement Endowment Trust, the Stephenson Cancer Center is decreasing the burden of cancer in Oklahoma by supporting innovative laboratory, clinical and populations-based research. The Stephenson Cancer Center has 200 research members who are conducting more than 165 cancer research projects at institutions across Oklahoma. This research is supported by $41.2 million in annual funding from the National Cancer Institute, the American Cancer Society and other sponsors.

Related Articles:

No Related Content Found



Related Materials